Enhanced Medication Therapy Management Continuing Education Sessions for Physicians

Tabula Rasa HealthCare’s (TRHC) OnDemand webinars are available from October 19, 2018 – December 17, 2018. These recordings are from TRHC’s well-received continuing education (CE) live sessions that took place in September 2018 in Minnesota and Iowa. There is no cost to participate in these OnDemand webinars. Participants will receive up to 2 hours of CE credits.


Target Audience

This activity is intended for physicians, nurses, pharmacists, and pharmacy technicians engaged in the care of all patients in the outpatient setting.

CE-Accredited Educational Objectives

After completing the activity, Opioid Pharmacology and Drug Interactions Affecting Opioid Response, participants should be better able to:

  • Explain the pharmacology of opioids
  • Recognize various mechanisms of opioid-related drug interactions
  • Discuss how competitive inhibition and genetic variants influence opioid response
  • Describe strategies for mitigating drug interactions influencing opioid response
  • Apply mitigating strategies to patient case scenarios to improve opioid prescribing

After completing the activity, Case Discussion: Multi-drug Interactions in Patients with Polypharmacy, participants should be better able to:

  • Explain the concepts related to substrates, inhibitors, and inducers
  • Comprehend the risk for multi-drug interactions associated with polypharmacy
  • Describe the fundamental principles of competitive inhibition
  • Apply these principles to patient case scenario(s) involving competitive inhibition

Additional Educational Objectives

After the Enhanced Medication Therapy Management (EMTM) activity, participants should be better able to:

  • Recognize the components of the model that characterize EMTM compared to traditional MTM
  • Identify benefits of EMTM in the patient care process
  • Describe the impact EMTM, including use of additional technology, can have on patient outcomes
  • Examine a series of cases where EMTM was implemented, with regards to identifying and ameliorating multi-drug interactions


Kevin T. Bain, PharmD, MPH, BCPS, BCGP, CPH, FASCP

Sr. Vice President, Research & Development, TRHC

Paul Iverson, BPharmD

President, Iverson Corner Drug, Inc.

Joshua Johnson, PharmD, BCGP

EMTM Lead, ClearStone Solutions

Kelly Kent, PharmD, BCPS

Director of Clinical Initiatives, Towncrest Pharmacy

Randy McDonough, BS, PharmD, MS, CGP, BCPS, FAPhA

Co-Owner, Towncrest Pharmacy

Other Information

All the finer details. For more information, contact us at RSVP@TRHC.com

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of Tabula Rasa HealthCare, Inc. TRHC is accredited by the ACCME to provide continuing medical education for physicians.

TRHC designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

TRHC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Opioid Pharmacology and Drug Interactions Affecting Opioid Response

TRHC designates this continuing education activity for 1 contact hours (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

  • Universal Activity Number – JA4008180-0000-18-010-H01-P Application
  • Universal Activity Number – – JA4008180-0000-18-010-H01-T Application

Case Discussion: Multi-Drug Interactions in Patients with Polypharmacy

TRHC designates this continuing education activity for 1 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

  • Universal Activity Number – JA4008180-0000-18-009-H04-P Knowledge
  • Universal Activity Number – JA4008180-0000-18-009-H04-T Knowledge

Continuing Nursing Education

Tabula Rasa HealthCare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity for 2 contact hour(s) is provided by TRHC.

Disclosure of Conflicts of Interest

TRHC requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to TRHC policy. TRHC is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.


The faculty members have nothing to disclose.

Planners and Managers

The TRHC planners and managers have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Request for Credit

A statement of credit may be downloaded within the webinar console upon successful viewing of the video, the post-test, and activity evaluation form.

Pharmacists: Upon completion of the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service.